Matthew Price, MD

Matthew J. Price, MD, is a professor of medicine and the director of the cardiac catheterization laboratory in the division of cardiovascular diseases at Scripps Clinic. He is a nationally recognized interventional cardiologist specializing in structural heart procedures and the latest non-invasive catheter-based treatments for heart disease. He is well known in Southern California among general cardiologists who refer patients with several types of coronary artery, valvular and structural heart disease.

Dr. Price specializes in both the percutaneous treatment of coronary artery disease and transcatheter/minimally invasive approaches to structural heart disease. He has substantial clinical experience in mitral and tricuspid edge-to-edge repair (“MitraClip” and “TriClip”), transcatheter mitral and tricuspid valve replacement, and implantation of the Watchman left atrial appendage device to prevent stroke in patients with atrial fibrillation (AFib). He also performs a broad range of other structural heart procedures, including atrial septal defect (ASD) and patent foramen ovale (PFO) closure, as well as complex coronary intervention.

In addition to his medical practice, Dr. Price has published extensively on his work and takes special interest in clinical research. He has authored or co-authored more than 200 publications in peer-reviewed academic journals, and twice has been awarded the Scripps Clinic Department of Medicine Chairman’s Award for Research in Medicine. He has also functioned as the editor of a major textbook on coronary stenting. He has served in the leadership of several clinical trials studying novel therapies for mitral and tricuspid valve disease, percutaneous approaches to treat heart failure, and new technologies to address calcified arteries during percutaneous coronary intervention. In 2024, Dr. Price was recognized by the American College of Cardiology National Cardiovascular Data Registry with a leadership award for his work in evaluating clinical outcomes after left atrial appendage device implantation in the United States.